Validity of an AI-Supported Whole-Body Electrical Stimulation Device for Spinal Pain Assessment: A Comparison With Self-Reported Pain Scores
Sponsor: Amasya University
Trial Details
| Condition | Chronic Back Pain |
| Status | Completed |
| Participants | 78 |
| Est. Completion | 15 Jan 2026 |
| Last Updated | 11 May 2026 |
Primary Outcome
Pain intensity measured by the StimaWELL 120MTRS system; Pressure pain threshold; Patient-reported pain
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Experiencing back pain for more than three months * Experiencing recurrent back pain over the last week * Not having used analgesic or muscle relaxant medications in the last week * Aged between 18 and 60 years * Diagnosed with chronic low back pain by a medical doctor * Literate and able to cooperate with study procedures * Willing to participate in the study Exclusion Criteria: * Having neurological, inflammatory, radiculopathy, vertebral fracture, or similar conditions * Experiencing acute-onset pain * Being pregnant or at risk of pregnancy * Having a psychiatric diagnosis and currently taking medication * Having a skin disease or lesion in the area where electrodes will be applied * Currently undergoing physical therapy * Having vestibular, auditory, or cognitive impairments * Possessing an electronic implant * Having a cardiac arrhythmia * Having a coronary or carotid stent * Being diagnosed with epilepsy * Having severe osteoporosis of the spine
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service